Moderna Inc
FDA authorizes Pfizer and Moderna’s Covid vaccines for children as young as 6 months
The Food and Drug Administration on Friday authorized Moderna’s and Pfizer’s Covid-19 shots for children as young as 6 months old, which makes nearly every person in the U.S. now eligible for vaccination. The FDA decision comes after its committee of independent vaccine experts voted unanimously to recommend the shots after weighing their safety and […]
Read More
Florida is the only state that hasn’t ordered Covid vaccines for kids under 5
Parents walk their children on the first day of school, amid the coronavirus (COVID-19) pandemic, at West Tampa Elementary School in Tampa, Florida, U.S., August 10, 2021. Octavio Jones | Reuters Florida parents with kids under 5 years old may find themselves waiting longer than the rest of the country to get their youngest children vaccinated […]
Read More
EU drugs watchdog launches rolling review of Pfizer-BioNTech’s Covid variant vaccine
A registered nurse prepares a dose of the Pfizer COVID-19 vaccine. Mario Tama | Getty Images The European Medicines Agency on Wednesday launched a rolling review of a variant-adapted Covid-19 vaccine developed by Pfizer and BioNTech, as cases of new sub-variants of the coronavirus’s Omicron lineage rise. When available, clinical trial data will be added […]
Read More
Stocks making the biggest moves premarket: Baidu, MicroStrategy, Moderna and more
Check out the companies making headlines before the bell: Baidu (BIDU) – Baidu shares jumped 4.1% in premarket trading after Reuters reported the China-based internet search giant is in talks to sell its controlling stake in the video streaming company iQIYI (IQ). iQIYI fell 3.4%. MicroStrategy (MSTR) – MicroStrategy lost 2.2% in the premarket as […]
Read More
FDA decision on Novavax’s Covid shots could be delayed to review changes in manufacturing
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images The Food and Drug Administration needs to review changes to Novavax’s manufacturing process before it can authorize the biotech […]
Read More
Stocks making the biggest moves midday: DocuSign, Campbell, Moderna and more
The Docusign Inc. website on a laptop computer arranged in Dobbs Ferry, New York, U.S., on Thursday, April 1, 2021. Tiffany Hagler-Geard | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Campbell Soup – The food company saw shares gain 2.3% after reporting a better-than-expected quarterly report. Campbell posted an […]
Read More
5 things to know before the stock market opens Wednesday
Here are the most important news, trends and analysis that investors need to start their trading day: 1. Stock futures fall with the 10-year Treasury yield above 3% Trader on the floor of the NYSE, June 7, 2022. Source: NYSE U.S. stock futures fell Wednesday after back-to-back gains on Wall Street. Adding pressure, the benchmark […]
Read More
Stocks making the biggest moves premarket: Campbell Soup, Moderna, Western Digital and others
Check out the companies making headlines before the bell: Campbell Soup (CPB) – The food producer’s shares rallied 3.7% in the premarket after Campbell reported an adjusted quarterly profit of 70 cents per share, 9 cents above estimates. Sales also beat forecasts, and the company raised its full-year sales outlook. Campbell also maintained its prior […]
Read More
Ford tops the list of the cheapest stocks in the market right now
While the short-term market outlook looks quite precarious, investors seeking buys for the long term are likely finding tons of value possibilities after the sizable pullback in stocks so far this year. CNBC PRO ran a screen looking for the cheapest stocks relative to the rest of the market and their historical valuations. Here’s the […]
Read More
Novavax faces high stakes FDA review this week that will decide the fate of its Covid vaccine in the U.S.
In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images Novavax’s Covid-19 vaccine will face the scrutiny of the Food and Drug Administration’s independent immunization experts this week, a crucial step on the path toward U.S. regulatory […]
Read More